Fabris P, Barnes E, Tositti G, Giordani M.T, De Lalla F. Therapy of Chronic Hepatitis C virus in HIV co-infected people. Curr Pharm Des. 2004,10,2111-2122
Lucas M, Vargas-Cuero AL, Lauer GM, Barnes E, Willberg CB, Semmo N, Walker BD, Phillips R, Klenerman P. Pervasive influence of hepatitis C Virus on the phenotype of CD8+ T cells. J Immunol 2004; 172(3): 1744-53
Barnes E *, Lauer GM *, Lucas M, Timm J, Ouchi K, Kim AY, Day CL, Robbins GK, Casson DR, Reiser M, Dusheiko G, Allen TM, Chung RT, Walker BD, Klenerman P. High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection. Gastroenterology. 2004 Sep; 127(3): 924-36.
Barnes E, Salio M, Cerundolo V, Medlin J, Murphy S, Dusheiko G, Klenerman P. Impact of alpha interferon and ribavirin on the function of maturing dendritic cells. Antimicrob Agents Chemother. 2004 Sep; 48(9): 3382-9.
Harcourt GC, Lucas M, Sheridan I, Barnes E, Phillips R, Klenerman P. Longitudinal mapping of protective CD4+ T cell responses against HCV: analysis of fluctuating dominant and subdominant HLA-DR11 restricted epitopes. J Viral Hepat. 2004 Jul;11(4):324-31.
Barnes E, Ward SM, Kasprowicz VO, Dusheiko G, Klenerman P, Lucas M. Ultra-sensitive class I tetramer analysis reveals previously undetectable populations of antiviral CD8+ T cells. Eur J Immunol. 2004 Jun; 34(6): 1570-7
Semmo N, Barnes E, Taylor C, Kurtz J, Harcourt G, Smith N and Klenerman P. T cell responses and prior exposure to HCV in “indeterminate” blood donors. Lancet 2005 Jan; 365 (9456): 327-9
Danta M, Barnes E, Dusheiko G. The surveillance and diagnosis of hepatocellular carcinoma. Eur J Gastro and Hepatology 2005 May; 17 (5): 491-6
Jansson A, Barnes E, Klenerman P, Harlén M, Sørensen P, Davis SJ, Nilsson P.A theoretical framework for quantitative analysis of the molecular basis of costimulation. J Immunol. 2005 Aug 1;175(3):1575-8
Barnes E, Salio M, Cerundolo V, Francesco L, Pardoll D, PauKlenerman P, Cox A. Monocyte derived dendritic cells retain their functional capacity in patients following infection with hepatitis C virus. J Viral Hepat. 2008 Mar;15(3):219-28.2007
Fabris P, Fleming VM, Giordani MT, Barnes E, Acute hepatitis C: clinical aspects, diagnosis, and outcome of acute HCV infection. Curr Pharm Des, 2008;14(17):1661-5
Pybus O*, Barnes E*, Taggart R, Lemey1 L, Markov P, Rasachak B, Syhavong B, Rattanaphone B, Sheridan I , Humphreys, Lu L, Newton P and Klenerman P; The Genetic History Of The Hepatitis C Virus In East Asia J Virol. 2009 Jan; 83(2):1071-82.
Barnes E, Gelderblom H, Humphreys I, Semmo N, Reesink H, Beld M, Van Lier R, Klenerman P. Cellular immune responses during high dose interferon-induction therapy for hepatitis C virus. J Infect Dis. 2009 Mar 15;199(6):819-28.
Rauch A, James I, Pfafferott K, Nolan D, Klenerman P, Cheng W, Mollison L, McCaughan G, Shackel N, Jeffrey GP, Baker R, Freitas E, Humphreys I, Furrer H, Günthard HF, Hirschel B, Mallal S, John M, Lucas M, Barnes E, Gaudieri S.Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure. Hepatology. 2009 Oct;50(4):1017-29.
Full-length characterization of hepatitis C virus subtype 3a reveals novel hypervariable regions under positive selection during acute infection.
Humphreys I, Fleming V, Fabris P, Parker J, Schulenberg B, Brown A, Demetriou C, Gaudieri S, Pfafferott K, Lucas M, Collier J, Huang KH, Pybus OG, Klenerman P, Barnes E. J Virol. 2009 Nov;83(22):11456-66. Epub 2009 Sep 9.